Literature DB >> 22491891

Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Edward F Domino1, Lisong Ni, Joseph S Domino, Wendy Yang, Catherine Evans, Sally Guthrie, Heng Wang, Robert A Koeppe, Jon-Kar Zubieta.   

Abstract

INTRODUCTION: Nicotine has long been recognized as a necessary but insufficient component of tobacco cigarettes to maintain a psychophysiological need to smoke. This study examined venous plasma concentrations effects of nicotine in cigarette smoking after overnight abstinence to release striatal dopamine (DA).
METHODS: Twenty-two male smokers smoked either denicotinized (denic) or average nicotine (nic) cigarettes under single blind conditions. Each was given [(11)C]raclopride and scanned in a positron emission tomography (PET) facility.
RESULTS: Smoking either denic or nic cigarettes released striatal DA. Denic cigarette smoking released DA primarily in the right striatum, whereas nic cigarette smoking released DA in both striata, but especially in the left. Increases in venous plasma nicotine concentrations correlated positively with increased DA release in the left caudate nucleus. Smoking denic cigarettes reduced craving as much as smoking nic cigarettes. Craving reduction after nic tobacco smoking correlated with increases in plasma nicotine.
CONCLUSIONS: Nonnicotine factors in tobacco smoking produce important right brain effects. Nicotine is a pharmacological factor during tobacco smoking that releases bilateral striatal DA, but more in the left brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491891      PMCID: PMC3524055          DOI: 10.1093/ntr/nts029

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  58 in total

Review 1.  Importance of nonpharmacological factors in nicotine self-administration.

Authors:  Anthony R Caggiula; Eric C Donny; Nadia Chaudhri; Kenneth A Perkins; F Fay Evans-Martin; Alan F Sved
Journal:  Physiol Behav       Date:  2002-12

2.  Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: a behavioral economic analysis.

Authors:  T A Shahan; W K Bickel; G J Madden; G J Badger
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

3.  Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking.

Authors:  Jesse Dallery; Elisabeth J Houtsmuller; Wallace B Pickworth; Maxine L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  2002-10-31       Impact factor: 4.530

4.  Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.

Authors:  Arthur L Brody; Edythe D London; Richard E Olmstead; Zoe Allen-Martinez; Stephanie Shulenberger; Matthew R Costello; Anna L Abrams; David Scheibal; Judah Farahi; Steven Shoptaw; Mark A Mandelkern
Journal:  Psychiatry Res       Date:  2010-08-03       Impact factor: 3.222

5.  Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Authors:  Fabio Marti; Ouafa Arib; Carole Morel; Virginie Dufresne; Uwe Maskos; Pierre-Jean Corringer; Renaud de Beaurepaire; Philippe Faure
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

6.  Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans.

Authors:  Sean P David; Briana Mezuk; Peter P Zandi; David Strong; James C Anthony; Raymond Niaura; George R Uhl; William W Eaton
Journal:  Nicotine Tob Res       Date:  2010-02-04       Impact factor: 4.244

7.  Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.

Authors:  Arthur L Brody; Mark A Mandelkern; Matthew R Costello; Anna L Abrams; David Scheibal; Judah Farahi; Edythe D London; Richard E Olmstead; Jed E Rose; Alexey G Mukhin
Journal:  Int J Neuropsychopharmacol       Date:  2008-08-18       Impact factor: 5.176

8.  The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats.

Authors:  Kelly J Clemens; Stephanie Caillé; Luis Stinus; Martine Cador
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-15       Impact factor: 5.176

9.  Venous plasma nicotine correlates of hormonal effects of tobacco smoking.

Authors:  Yue Xue; Mark Morris; Lisong Ni; Sally K Guthrie; Jon-Kar Zubieta; Kimberly Gonzalez; Daniel S McConnell; Edward F Domino
Journal:  Pharmacol Biochem Behav       Date:  2010-01-25       Impact factor: 3.533

10.  The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers.

Authors:  Sean P Barrett
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

View more
  14 in total

Review 1.  Withdrawal: Expanding a Key Addiction Construct.

Authors:  Megan E Piper
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

2.  Neuroimaging in Alcohol and Drug Dependence.

Authors:  Mark J Niciu; Graeme F Mason
Journal:  Curr Behav Neurosci Rep       Date:  2014-03-01

3.  Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans.

Authors:  Bernard Le Foll; Mihail Guranda; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Victoria C Wing; Laurie Zawertailo; Usoa Busto; Peter Selby; Arthur L Brody; Tony P George; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

Review 4.  A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.

Authors:  Thulasi Thiruchselvam; Saima Malik; Bernard Le Foll
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-30       Impact factor: 3.829

Review 5.  Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Authors:  Agnes J Jasinska; Todd Zorick; Arthur L Brody; Elliot A Stein
Journal:  Neuropharmacology       Date:  2013-03-06       Impact factor: 5.250

6.  Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.

Authors:  Emily B Nuechterlein; Lisong Ni; Edward F Domino; Jon-Kar Zubieta
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-17       Impact factor: 5.067

7.  Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy.

Authors:  Jason D Robinson; Francesco Versace; Jeffery M Engelmann; Yong Cui; David G Gilbert; Andrew J Waters; Ellen R Gritz; Paul M Cinciripini
Journal:  J Psychopharmacol       Date:  2016-04-19       Impact factor: 4.153

8.  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Authors:  Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

9.  Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling.

Authors:  Merideth A Addicott; Brett Froeliger; Rachel V Kozink; Dana M Van Wert; Eric C Westman; Jed E Rose; Francis J McClernon
Journal:  Neuropsychopharmacology       Date:  2014-05-13       Impact factor: 7.853

10.  Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers.

Authors:  Daniel S Albrecht; David A Kareken; Karmen K Yoder
Journal:  Brain Imaging Behav       Date:  2013-09       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.